Bordetella Petrii Recovered from Chronic Pansinusitis in an Adult with Cystic Fibrosis

Bordetella Petrii Recovered from Chronic Pansinusitis in an Adult with Cystic Fibrosis

Thomas Jefferson University Jefferson Digital Commons Department of Pathology, Anatomy, and Cell Department of Pathology, Anatomy, and Cell Biology Faculty Papers Biology 2015 Bordetella petrii recovered from chronic pansinusitis in an adult with cystic fibrosis Laura Biederman Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College at Thomas Jefferson University Marc Rosen MD Department of Otolaryngology-Head and Neck Surgery, Sidney Kimmel Medical College at Thomas Jefferson University Brent S. Bobik Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College at Thomas Jefferson University Amity L. Roberts, PhD, D(ABMM) Follow this and additional works at: https://jdc.jefferson.edu/pacbfp Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College at Thomas Jefferson Univ Persityart of the Pathology Commons Let us know how access to this document benefits ouy Recommended Citation Biederman, Laura; Rosen, Marc MD; Bobik, Brent S.; and Roberts, PhD, D(ABMM), Amity L., "Bordetella petrii recovered from chronic pansinusitis in an adult with cystic fibrosis" (2015). Department of Pathology, Anatomy, and Cell Biology Faculty Papers. Paper 178. https://jdc.jefferson.edu/pacbfp/178 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Department of Pathology, Anatomy, and Cell Biology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact: [email protected]. IDCases 2 (2015) 97–98 Contents lists available at ScienceDirect IDCases jo urnal homepage: www.elsevier.com/locate/idcr Case Report Bordetella petrii recovered from chronic pansinusitis in an adult with cystic fibrosis a b a a, Laura Biederman , Marc R. Rosen , Brent S. Bobik , Amity L. Roberts * a Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Pavilion Building, Suite 207, Philadelphia, PA 19107, USA b Department of Otolaryngology-Head and Neck Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, 925 Chestnut Street, 6th Floor, Philadelphia, PA 19107, USA A R T I C L E I N F O A B S T R A C T Article history: To date Bordetella petrii has infrequently been identified within the clinical setting likely due to the Received 1 August 2015 asaccharolytic nature of this organism. We present a case of B. petrii recovered on two separate events in Received in revised form 16 September 2015 a patient with adult cystic fibrosis experiencing chronic pansinusitis. Accepted 16 September 2015 ß 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Keywords: Bordetella petrii Pansinusitis Adult cystic fibrosis MALDI-TOF Case report organisms. Twenty-four hours post-incubation, moderate growth of a tiny Gram-negative colony was noted on trypticase soy agar We present a 41-year old female with a 20 plus year history of with 5% sheep blood (Becton, Dickinson and Company, Franklin nasal obstruction and chronic sinusitis. Her clinical history Lakes, NJ). No other organisms were recovered. By 48 h, growth indicated velopharyneal insufficiency (incomplete closure of the was noted on the MacConkey agar (Becton, Dickinson and velopharyngeal sphincter between the oropharynx and the Company, Franklin Lakes, NJ). The isolate was identified by the nasopharynx), severe gastroparesis, significant gastric reflux and Bruker Biotyper MALDI-TOF MS system (Bruker Daltonics Inc., asthma contributed to a confirmed cystic fibrosis mutation, DF508 Billerica, MA) as Bordetella petrii (score 2.13; highly probable gene. Individuals diagnosed with adult cystic fibrosis frequently species identification). Since the organism had not been validated experience gastroparesis, asthma and chronic sinusitis [1,2]. by this method, the isolate was tested by the Microscan NBPC30 Historically, the patient underwent several surgical interven- panel for oxidase positive organisms (Siemens Medical Solutions tions, multiple rounds of antimicrobials, decongestants, antihis- USA, Inc., Malvern, PA) and the Remel RapID NF PLUS System tamines, topical and oral steroids without improvement of her (Thermo Fisher Scientific Remel Products, Lenexa, KS). The NBPC30 diffuse pansinusitis. In an attempt to alleviate her chronic sinusitis, panel identified the organism as Alcaligenes species (00064326) revision endoscopic sinus surgery with septoplasty and a 79.12%. The RapID system identified the organism as Alcaligenes turbinectomy was performed during early 2014 (day 0). A right xylosoxidans (210606) Implicit. Both B. petrii and Alcaligenes species maxillary sinus tissue specimen was sent for aerobic bacterial are asachrolytic organisms and part of the Alcaligenaceae family culture, which was incubated aerobically only with 5% CO2 at 35 8C. [3]. The isolate exhibited the following phenotypic characteristics: The specimen Gram-stain showed few white-blood cells and no non-motile; oxidase, catalase, and nitrate positive; urea negative; malate, tartrate and citrate positive, this phenotype is consistent throughout literature [3–6]. For more stringent confirmation, 16S * Corresponding author at: Department of Pathology, Anatomy and Cell Biology, rRNA sequencing was performed at ARUP laboratories and Sidney Kimmel Medical College at Thomas Jefferson University, 117 S 11th Street, provided an identification of B. petrii (Salt Lake City, UT). No Pavilion Suite 207, Philadelphia, PA 19107, USA. Tel.: +1 215 955 8726; standard antibiotic susceptibility guidelines are defined for this fax: +1 215 955 2519. organism; however, antimicrobial susceptibility test (AST) results E-mail addresses: [email protected] (L. Biederman), for the two isolates are shown in Table 1 for epidemiologic strain [email protected] (M.R. Rosen), [email protected] (B.S. Bobik), [email protected] (A.L. Roberts). differentiation. http://dx.doi.org/10.1016/j.idcr.2015.09.004 2214-2509/ß 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/ 4.0/). 98 L. Biederman et al. / IDCases 2 (2015) 97–98 Table 1 There has been a limited number of case reports with B. petrii defined Results of antimicrobial susceptibility testing for both isolate one and two. as the etiologic agent [4,5,7–10]. B. petrii has been implicated as the Antimicrobial agent Isolate one Isolate two causative agent in cases of mandibular osteomyelitis, chronic MIC (mg/mL) MIC (mg/mL) suppurative mastoiditis, chronic pulmonary obstructive disease and persistent bronchiectasis [4,8–10]. Importantly, it has been previ- Ampicillin >16 >16 ously isolated from in cystic fibrosis patients [5,7]. Ampicillin/sulbactam 16/8 16/8 Amikacin 16 16 Because it is uncommon, or likely misidentified, accurate Amoxicillin/K Clavulanate 8/4 8/4 identification of B. petrii represents a challenge for traditional Gentamicin 8 4 automated identification systems. These biochemical or enzymatic Imipenem 4 4 systems are only marginally effective, due to the lack of a distinct Levofloxacin 2 2 Ciprofloxacin >2 >2 biochemical carbohydrate profile as well as limited or uncurated Moxifloxacin 4 4 databases. Not only was B. petrii mis-identified by MicroScan Gatifloxacin 2 2 (NBPC30) and rapID panels in the two described occasions for this Norfloxacin >8 >8 patient, but it was also misidentified in other reported cases Piperacillin/tazobactam 16/4 16/4 [10]. Studies show that Bordetella species are closely related to Tetracycline 4 4 Ticarcillin/K clavulanate 16 16 Achromobacter (Algaligenes) species [6,11]. The case patient had Tobramycin 4 4 two sinus isolates identified three years prior as Achromobacter Trimethoprim/sulfamethoxazole 2/38 2/38 species (90%) by the BD Phoenix NMIC/ID-124 panel (Becton- Aztreonam >16 >16 Dickinson, Sparks, MD). Unfortunately, these isolates are no longer Cefepime >16 >16 Cefuroxime >16 >16 available to determine if they were misidentified. The gold Cefazolin >16 >16 standard method for identification of B. petrii is 16S rRNA Cephalothin >16 >16 sequencing [4,8,10]. At that time the patient was treated post- Cefoxitin >16 >16 operatively with 1000 mg of cefazolin (MIC > 16 mg/mL), indicat- Cefotetan >32 >32 ing inadequate coverage. Cefotaxime >32 >32 Ceftazidime 8 >16 The importance of B. petrii as a clinical pathogen has not been Ceftriaxone >32 >32 well established; however, it has been described in cystic fibrosis Meropenem >8 >8 patients [1,2,5,7]. B. petrii has been demonstrated to persist despite Chloramphenicol >16 >16 treatment in patients, as was potentially noted with her previous Meropenem 4 4 Piperacillin 16 16 isolates of Achromobacter species [7,10]. By using the MALDI-TOF Nitrofurantoin >64 >64 methodology the clinical laboratory can achieve not only quicker but more accurate organism identifications. More accurate Microscan NBPC30 for oxidase

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    3 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us